Weight-Loss Drug Mounjaro: A Food Critic’s Reflections & Impact on the Industry

Katy McGuinness, restaurant critic for the Irish Independent, has publicly disclosed her experience taking Mounjaro, a weight-loss drug, and the impact it has had on her relationship with food and her profession. McGuinness initially hesitated to begin the medication, fearing it would compromise her ability to critically assess culinary experiences.

“I’d be lying if I said I wasn’t concerned about how taking Mounjaro would affect my ability to do my job,” McGuinness stated, explaining her initial reluctance. Her concern stemmed from a long-held belief, echoed by Mimi Sheraton, the first female restaurant critic for The New York Times, that a deep engagement with food – even to the point of overeating – is essential to the role. Sheraton, in a 1987 interview with Terry Gross, suggested that many successful food critics are driven by a desire to eat, stating, “I would have to say that I probably have pursued this career as an excuse to overeat. I think that the people who are really good at it are all in that position.”

McGuinness has reported significant physical changes since starting Mounjaro, including a weight loss of 20kg and a reduction in blood pressure. She also noted being able to wear clothes she hadn’t fit into for years. The critic’s experience comes as the use of GLP-1 medications, like Mounjaro, becomes more widespread, prompting reflection on the potential implications for the food industry.

The rise of these medications is expected to reshape the landscape of food consumption and potentially alter the very nature of culinary appreciation, according to McGuinness. She is currently considering what the increasing prevalence of GLP-1s will mean for the restaurants she reviews and the broader food culture she observes.